A novel immunotherapy to treat HCV infection.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/543144

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

It is possible to cure some patients with HCV infection but the current therapy is very costly and produces numerous side effects in treated individuals. We propose to treat patients using a new therapy in which HCV proteins are first expressed in blood cells ex vivo and the cells then manipulated to generate dying cells. These will be injected into the same patient from which they were collected initially and are expected to elicit high levels of HCV immunity with the potential for cure.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $568,088.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell mediated immunity | cell therapy | hepatitis C virus | immune response. | infectious disease | liver | neutralising antibody | therapy | viral clearance

Related Links